Metabolism of Tryptophan, Glutamine, and Asparagine in Cancer Immunotherapy—Synergism or Mechanism of Resistance?
Kajetan Kiełbowski,
No information about this author
Estera Bakinowska,
No information about this author
Rafał Becht
No information about this author
et al.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(3), P. 144 - 144
Published: Feb. 21, 2025
Amino
acids
are
crucial
components
of
proteins,
key
molecules
in
cellular
physiology
and
homeostasis.
However,
they
also
involved
a
variety
other
mechanisms,
such
as
energy
homeostasis,
nitrogen
exchange,
further
synthesis
bioactive
compounds,
production
nucleotides,
or
activation
signaling
pathways.
Moreover,
amino
their
metabolites
have
immunoregulatory
properties,
significantly
affecting
the
behavior
immune
cells.
Immunotherapy
is
one
oncological
treatment
methods
that
improves
cytotoxic
properties
one’s
own
system.
Thus,
enzymes
catalyzing
acid
metabolism,
together
with
themselves,
can
affect
antitumor
responses
to
immunotherapy.
In
this
review,
we
will
discuss
involvement
tryptophan,
glutamine,
asparagine
metabolism
cells
targeted
by
immunotherapy
summarize
results
most
recent
investigations
on
impact
Language: Английский
α-Ketoglutarate modulates the mechanisms of toxicity in crucian carp kidneys chronically exposed to NaHCO3: Metabolomics insights
Wenzhi Liu,
No information about this author
Lin Han,
No information about this author
Fangying Yuan
No information about this author
et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics,
Journal Year:
2025,
Volume and Issue:
55, P. 101466 - 101466
Published: March 4, 2025
Language: Английский
Ethyl acetate extract from Herpetospermun cardigerum Wall. Ameliorated Concanavalin A-induced autoimmune hepatitis in mice by reprofiling gut microenvironment to modulate IDO1/KYN and PI3K/AKT/NF-κB pathways
Xiao Yu,
No information about this author
Tao Luo,
No information about this author
Changsong Duan
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119578 - 119578
Published: March 1, 2025
Language: Английский
Gut Barrier, Microbial Metabolites, and Immune Homeostasis in Autoimmune Hepatitis: From Molecular Mechanisms to Strategies
Xintong Zhang,
No information about this author
Lin‐Yan Wan,
No information about this author
Yujiao Zheng
No information about this author
et al.
Frontiers in Bioscience-Landmark,
Journal Year:
2025,
Volume and Issue:
30(5)
Published: April 30, 2025
Autoimmune
hepatitis
(AIH)
is
a
chronic
immune-mediated
inflammatory
liver
disease
characterized
by
recurring
immune-triggered
hepatic
injury.
While
scientists
have
yet
to
fully
elucidate
the
precise
triggers
of
AIH,
contemporary
research
indicates
that
both
gut
microbiota
and
their
metabolic
products
significantly
influence
AIH
progression.
These
factors
contribute
multiple
mechanisms,
including
compromised
intestinal
barrier
function,
altered
microbial
metabolite
trafficking,
disrupted
immune
balance,
leading
responses.
This
review
begins
exploring
populations
byproducts
linked
AIH.
It
highlights
how
flora
compromises
defenses,
enables
bacterial
migration
from
tissue,
induces
Research
validates
microbes,
such
as
short-chain
fatty
acids
(SCFAs),
bile
(BAs),
specific
amino
(glutamine,
cysteine,
tryptophan,
branched-chain
variants,
among
others),
interact
with
cell
populations.
interactions,
coupled
modifications,
Our
identifies
promising
treatment
strategies,
use
probiotic
supplementation,
engineered
prebiotic
compounds,
transfer
procedures,
medications
targeting
microorganisms
byproducts.
approaches
could
potentially
reduce
damage,
offering
potential
new
avenues
for
management.
Language: Английский
Genetically predicted immune cells mediate the association between gut microbiota and autoimmune liver diseases
Jikang Zhang,
No information about this author
Yiqi Hu,
No information about this author
Jin Xu
No information about this author
et al.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 16, 2024
Increasing
evidence
suggests
an
association
between
gut
microbiota
and
Autoimmune
Liver
Diseases
(AILDs).
However,
causal
inference
remains
controversial
due
to
confounding
bias
in
observational
studies.
Additionally,
there
is
currently
no
clear
indicating
that
immune
cells
act
as
intermediate
phenotypes
the
pathogenesis
of
AILDs.
This
study
utilizes
Mendelian
Randomization
(MR)
method
investigate
relationships
among
microbiota,
cells,
Language: Английский